Skip to main content
. 2018 Sep 25;36(6):479–486. doi: 10.1159/000493389

Table 3.

Survival after hepatic resection for metastatic sarcoma

Study n Follow-up, median/months Survival
Jaques et al. [2], 1995 14 60 Median OS 30 months, 5-year OS was 0%*
Harrison et al. [24], 1997 27 60 Median OS 31 months, 5-year OS was 4%*
Elias et al. [25], 1998 13 Unknown 5-Year OS 18%*
Chen et al. [26], 1998 11 53 Median OS 39 months*
Lang et al. [27], 2000 26 Unknown Median OS after R0 resection: 32 months, 5-year OS 13%
DeMatteo et al. [8], 2001 22 25 Median OS 30 months
Pawlik et al. [16], 2006 66 35.8 1-Year OS 91.2%, 5-year OS 27%**
Adam et al. [23], 2006 125 Mean FU: 31 months Median OS 32 months, 5-year OS 31%
Lendoire et al. [28], 2007 23 28 5-Year OS 0%
Rehders et al. [29], 2009 27 84 Median OS 44 months, 5-year OS 49%^
Chua et al. [22], 2011 15 122 Median OS 103 months, 5-year OS: 51%, 10-year OS: 37%^
Marudanayagam et al. [11], 2011 36 24 Median OS 24 months, 5-year OS 32%^
Zacherl et al. [30], 2011 15 Unknown Median OS 34 months, 5-year OS 27%^
Groeschl et al. [9], 2012 98 32 Median OS 72 months, 1-year OS: 82%, 5-year OS 32%***
Brudvik et al. [10], 2015 50 32 Median OS 45 months, 5-year OS 45%, 10-year OS 23%
*

Study population included before 1996.

**

Study population included 36 Gastrointestinal stromal tumours, 13 patients were treated with RFA only.

***

Excluded all R1- and R2-resections.

^

Study population included Sarcomas and Gastrointestinal stromal tumours.